According to Merck's latest financial reports the company's current EPS (TTM) is โน155.54. In 2022 the company made an earnings per share (EPS) of โน489.23 an increase over its 2021 EPS that were of โน441.06.
Year | EPS | Change |
---|---|---|
2023 (TTM) | โน152.41 | -68.85% |
2022 | โน489.23 | 10.92% |
2021 | โน441.06 | 84.68% |
2020 | โน238.83 | -27.2% |
2019 | โน328.05 | 63.44% |
2018 | โน200.71 | 151.11% |
2017 | โน79.93 | -54.58% |
2016 | โน175.96 | 30.21% |
2015 | โน135.14 | -61.99% |
2014 | โน355.50 | 180.51% |
2013 | โน126.73 | -31.82% |
2012 | โน185.87 | 6.62% |
2011 | โน174.33 | 626.78% |
2010 | โน23.99 | -95.05% |
2009 | โน484.60 | 56.36% |
2008 | โน309.93 | -449.04% |
2007 | -โน88.80 | -150.98% |
2006 | โน174.18 | -3.32% |
2005 | โน180.15 | -20.08% |
2004 | โน225.40 | -10.81% |
2003 | โน252.72 | -6.92% |
2002 | โน271.51 | 0% |
2001 | โน271.51 | 7.43% |
2000 | โน252.72 | 17.93% |
1999 | โน214.30 | 13.06% |
1998 | โน189.54 | 15.63% |
1997 | โน163.93 | 20% |
1996 | โน136.61 |